← Back to Search

Behavioral Intervention

Lifestyle Program for Obstructive Sleep Apnea with Obesity

N/A
Recruiting
Led By Roberto Benzo, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Newly diagnosed with severe Obstructive Sleep Apnea (OSA) and severe obesity (BMI > 35).
Adult patients, 18 years of age or older.
Must not have
Patients with an inability to provide good data or follow commands (patients who are disoriented, have a severe neurologic or psychiatric condition).
Individuals < 18 years of age.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up qualitative interviews will be completed at the end of the two week trial
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new remote monitoring system for people with severe obesity and sleep apnea. The system will provide health coaching to help participants make behavior changes that improve their health and quality of life.

Who is the study for?
This trial is for adults over 18 with severe obesity (BMI > 35) and newly diagnosed with severe Obstructive Sleep Apnea. It's not suitable for those under 18 or patients who can't provide accurate data or follow instructions due to serious neurological or psychiatric conditions.
What is being tested?
The study is testing a home-based pulmonary rehabilitation system designed to help people with severe obesity and sleep apnea. The program includes remote monitoring and health coaching to encourage lifestyle changes that improve health and quality of life.
What are the potential side effects?
Since the intervention involves lifestyle modification rather than medication, typical drug side effects are not expected. However, participants may experience fatigue or muscle soreness from increased physical activity.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am newly diagnosed with severe sleep apnea and have a BMI over 35.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am able to understand and follow study instructions.
Select...
I am under 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~qualitative interviews will be completed at the end of the two week trial
This trial's timeline: 3 weeks for screening, Varies for treatment, and qualitative interviews will be completed at the end of the two week trial for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Feasibility of proposed system in patients with OSA and Obesity

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Severe Comorbid OSAExperimental Treatment1 Intervention
Newly-diagnosed severe comorbid obstructive sleep apnea subjects will use technology to facilitate remote health coaching through a home-based pulmonary rehabilitation (PR) system

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,324 Previous Clinical Trials
3,059,385 Total Patients Enrolled
87 Trials studying Obesity
9,117 Patients Enrolled for Obesity
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,922 Previous Clinical Trials
47,760,726 Total Patients Enrolled
254 Trials studying Obesity
211,471 Patients Enrolled for Obesity
Minnesota HealthSolutionsIndustry Sponsor
13 Previous Clinical Trials
1,560 Total Patients Enrolled

Media Library

Home-based pulmonary rehabilitation (PR) system (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05343000 — N/A
Obesity Research Study Groups: Severe Comorbid OSA
Obesity Clinical Trial 2023: Home-based pulmonary rehabilitation (PR) system Highlights & Side Effects. Trial Name: NCT05343000 — N/A
Home-based pulmonary rehabilitation (PR) system (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05343000 — N/A
~11 spots leftby Nov 2025